• Vascutek website

  • Terumo Group website

7 April 2014

Vascutek’s AnacondaTM AAA Stent Graft System Approved for Expanded Indication

Vascutek is pleased to announce that it has received CE mark approval for AnacondaTm to be used to treat infra-renal abdominal aortic aneurysms in patients with proximal aortic neck angulation of ≤ 90 degrees providing a clinical solution for patients with tortuous anatomy.

The AnacondaTM stent graft is designed to deliver exceptional flexibility with innovative ring stent technology to provide a proactive sealing system which conforms to the natural anatomy of the patient. The ability to fully reposition enables clinicians to deliver the system accurately to the target even in challenging anatomy.

Vascutek’s Vice-President of Sales, Marketing and Clinical Services, Alan Rogers, said: “As EVAR techniques have evolved over the years, AnacondaTM has provided clinicians with a solution for a wide-range of patient anatomies.”

The 90 degree indication for AnacondaTM provides clinicians with a treatment to manage those patients presenting with challenging anatomies.

The AnacondaTM Stent Graft System is used to treat abdominal aortic aneurysms. More than 17,000 AnacondaTM stent grafts have been implanted since the system was launched in 2005.

 

Media Contact:
Natalie Buxton
Weber Shandwick
Tel: 00 44 141 333 0557
Mobile: +44 7770 886934

This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact Vascutek

VASCUTEK, a TERUMO Company
Registered Office:
Newmains Avenue
Inchinnan
Renfrewshire PA4 9RR
Scotland UK

General Enquiries
This email address is being protected from spambots. You need JavaScript enabled to view it.
Tel: 00 44 141 812 5555
Fax: 00 44 141 812 7170


© 2011 Vascutek Ltd. a Terumo Company